期刊文献+

微生态制剂对TNBS诱导的大鼠结肠炎的疗效

Therapeutic effect of a probiotic compound on TNBSinduced colitis in rats
暂未订购
导出
摘要 目的:评价双歧三联活菌对三硝基苯磺酸钠(TNBS)诱导的大鼠结肠炎的疗效,并探讨其作用机制.方法:成年♀SD大鼠(n=50),随机分为健康对照组A、未治疗组B、双歧三联活菌治疗组C、奥沙拉秦治疗组D、双歧三联活菌和奥沙拉秦联合治疗组E(n=10).观察大鼠的一般情况,检测各组大鼠血清肿瘤坏死因子-α(TNF-α)、结肠组织TNF-α细胞阳性率,比较结肠组织炎症程度.结果:A组大鼠DAI(P<0.001)、血清TNF-α(P<0.001)水平、肠组织TNF-α细胞阳性率(P<0.05)、肠组织学评分(P<0.05)显著低于未治疗组B;B组大鼠DAI、血清TNF-α水平、肠组织学评分、肠组织TNF-α细胞阳性率最高(P<0.05);3个治疗组C、D、E的大鼠DAI、血清TNF-α、肠组织TNF-α细胞阳性率明显下降,肠组织炎症明显消散,以E组最显著(P<0.05),肠组织TNF-α的表达与结肠炎病情轻重呈正相关.结论:双歧三联活菌能有效治疗TNBS诱导的大鼠结肠炎,其作用机制可能与抑制肠黏膜免疫系统效应细胞TNF-α的表达有关. AIM: To evaluate the therapeutic effect of a pro- biotic compound on colitis in rats induced with trinitrobenzenesulfonic acid (TNBS) and to in- vestigate the underlying mechanisms. METHODS: In total, 50 female adult Sprague- Dawley rats were randomized into five groups: healthy control group (A), untreated group (B), probiotics group (C), olsalazine group (D) and combined treatment group (E). Except for groupA, rats in the other groups were subjected to induction of colitis. Each group received a corre- sponding therapeutic regimen. After treatment, the general status of all rats was observed; serum levels of tumor necrosis factor-alpha (TNF-α) and positive rate of colonic TNF-α expression in the colon were detected; and histopathologic changes in the colon were examined. RESULTS: The disease activity index (DAI), serum levels of TNF-α, positive rate of TNF-α expression in the colon, and histopathologic score were significantly lower in group A than in group B (all P 〈 0.05). Group B exhibited most severe colonic inflammation and highest DAI, serum TNF-α, and positive rate of TNF-α expression in the colon (all P 〈 0.05). The three treatment groups (C, D and E) showed marked remission of colonic inflammation and signifi- cantly decreased serum TNF-α and positive rate of TNF-α in the colon when compared to group B (all P 〈 0.05), with group E being most promi- nent. Colonic TNF-α expression correlates posi- tively with the severity of colitis. CONCLUSION: The tested probiotic compound could effectively reduce TNBS-induced colitis in rats possibly via mechanisms associated with the inhibition of TNF-α expressed by the effector cells of intestinal mucosal immune system.
出处 《世界华人消化杂志》 CAS 北大核心 2012年第1期66-69,共4页 World Chinese Journal of Digestology
基金 研究生自行设计研究基金资助项目~~
关键词 结肠炎 三硝基苯磺酸钠 微生态制剂 肿瘤坏死因子 Colitis Trinitrobenzenesulfonic acid Probiotics Tumor necrosis factor-alpha
  • 相关文献

参考文献6

  • 1Schreiber S,Nikolaus S,Hampe J,H?mling J,Koop I,Groessner B,Lochs H,Raedler A.Tumour necro-sis factor alpha and interleukin1beta in relapse of Crohn’s disease.Lancet1999;353:459-461.
  • 2陈宁,尤鹏,刘安楠,刘玉兰.益生菌治疗的实验性结肠炎中调节性T细胞的作用[J].中华消化杂志,2006,26(2):100-103. 被引量:7
  • 3Siddiqui A,Ancha H,Tedesco D,Lightfoot S,Stew-art CA,Harty RF.Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis.Dig Dis Sci2006;51:698-705.
  • 4Vowinkel T,Kalogeris TJ,Mori M,Krieglstein CF,Granger DN.Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis.Dig Dis Sci2004;49:556-564.
  • 5Fedorak RN,Empey LR,MacArthur C,Jewell LD.Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats.Gas-troenterology1990;98:615-625.
  • 6Hanauer SB,Feagan BG,Lichtenstein GR,Mayer LF,Schreiber S,Colombel JF,Rachmilewitz D,Wolf DC,Olson A,Bao W,Rutgeerts P.Maintenance infliximab for Crohn’s disease:the ACCENT I ran-domised trial.Lancet2002;359:1541-1549.

二级参考文献15

  • 1Keighley MR,Stockbrugger RW.Inflammatory bowel disease.Aliment Pharmacol Ther,2003,18(Suppl 3):66-70.
  • 2Ishikawa H,Akedo I,Umesaki Y,et al.Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis.J Am Coll Nutr,2003,22:56-63.
  • 3Malchow HA.Crohn's disease and Escherichia coll A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol,1997,25:653-658.
  • 4Sartor RB.Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases:antibio-tics,probiotics and prebiotics.Gastroenterology,2004,126:1620-1633.
  • 5Morris GP,Beck PL,Herridge MS,et al.Hapten-induced model of chronic inflammation and ulceration in the rat colon.Gastroenterology,1989,96:795-803.
  • 6Fuss IJ,Boirivant M,Lacy B,et al.The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis.J Immunol,2002,168:900-908.
  • 7Davies MD,Parrott DM.Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine.Gut,1981,22:481-488.
  • 8Schultz M,Veltkamp C,Dieleman LA,et al.Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10 deficient mice.Inflamm Bowel Dis,2002,8:71-80.
  • 9McCarthy J,O'Mahony L,O'Callaghan L,et al.Double blind,placebo controlled trial of two probiotic strains in interleukin 10knockout mice and mechanistic link with cytokine balance.Gut,2003,52:975-980.
  • 10Mottet C,Uhlig HH,Powrie F.Cutting edge:cure of colitis by CD4+CD25+regulatory T cells.J Immunol,2003,170:3939-3943.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部